Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.53T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  EW

Edwards Lifesciences Corp

EW
71 / 100
S&P500
$86.15arrow_drop_down-1.81%-$1.59
Key Stats
Open$87.92
Prev. Close$87.62
EPS2.3
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$52.75B
PE Ratio38.15
LOWHIGH
Day Range87.37
88.33
52 Week Range60.57
94.87
Ratios
P/B Ratio7.93
Revenue$6.00B
Operating M. %39.40%
Earnings$1.39B
Earnings Growth %-8.05%
EBITDA Margin %31.22%
ROE %22.34%
EPS2.3
Fundamentals
RPS$9.90
Gross Profit$4.62B
EBITDA$1.94B
Total Debt$694.89M
P/S Ratio8.7x
Enterprise to EBITDA29.43
Profit Margin23.36%
ROA12.25%
Debt/Equity Ratio0.10%
Payout Ratio-
Industry average yield3.02%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

EWarrow_drop_up0.14%
US Healthcare Sectorarrow_drop_up0.65%
US Marketarrow_drop_up0.51%
EW / Market
EW lose to the US Market which returned 0.51% over the last twenty four hours.
EW / Healthcare Sector
EW lose to the US Healthcare sector which returned 0.65% over the last twenty four hours.

Edwards Lifesciences Corp (EW) Statistics

Edwards Lifesciences Corp (EW) is a leading medical technology company that specializes in innovative solutions for structural heart disease and critical care monitoring. The company is known for its expertise in heart valve replacement and repair, as well as minimally invasive surgical procedures. With a market capitalization of over $50 billion, EW is recognized as one of the largest players in the cardiovascular space.

When it comes to statistics, Edwards Lifesciences Corp has an impressive track record. The company has consistently outperformed its sector and delivered strong financial results year after year. In terms of valuation metrics, EW boasts a favorable price-to-earnings ratio and a healthy return on equity. These numbers indicate that investors have confidence in the company's ability to generate profits and create value.

add Edwards Lifesciences Corp to watchlist

Keep an eye on Edwards Lifesciences Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has Edwards Lifesciences Corp (EW) stock's performance compared to its sector and the market over the past year?

Over the past year, Edwards Lifesciences Corp (EW) has experienced a price change of 13.49%. Compared to the Healthcare sector, which saw a change of 35.19%, Edwards Lifesciences Corp has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.12%, it has fallen short of the market average. This comparison highlights Edwards Lifesciences Corp's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of Edwards Lifesciences Corp (EW) stock?

The PE (Price to Earnings) ratio of Edwards Lifesciences Corp (EW) is currently 38.15. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of Edwards Lifesciences Corp (EW) stock?

The Earnings Per Share (EPS) for Edwards Lifesciences Corp (EW), calculated on a diluted basis, is $2.3. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of Edwards Lifesciences Corp (EW) stock?

The operating margin for Edwards Lifesciences Corp (EW) is 39.4%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of Edwards Lifesciences Corp (EW) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Edwards Lifesciences Corp (EW) is $1.94B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does Edwards Lifesciences Corp (EW) have?

Edwards Lifesciences Corp (EW) has a total debt of $694.9M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$449.1M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.